Bénédicte Menn

Private Equity Investor bij

Oxford University Innovation Ltd.

Consumer Services

Finance

Health Technology

Profiel

Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.

Actieve functies van Bénédicte Menn

Bedrijven	Functie	Begin
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Private Equity Investor	01-01-2017

Alle actieve functies van Bénédicte Menn

Eerdere bekende functies van Bénédicte Menn

Bedrijven	Functie	Einde
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Oprichter	11-03-2014

Ervaring van Bénédicte Menn in detail bekijken

Opleiding van Bénédicte Menn

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Bénédicte Menn in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	3
Ecole Nationale d'Administration Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Finance
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Health Technology